News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
Theranos Cleans House, Gets Rid of Some High-Profile Board Members 12/2/2016
Floundering SoCal Biotech Arrowhead Pharma (ARWR) Fires CSO, Effective Later This Month 12/2/2016
2 Bay Area and 1 Massachusetts Biotech Stocks That Could Double in 2017 12/2/2016
Another Reason Biotech's Trump-Bump Won't Last 12/2/2016
It's Confirmed! Merck & Co. (MRK) Inks Huge Space in the Bay Area 12/1/2016
High School Students "Punched" Martin Shkreli in the Face by Recreating $750 HIV Pill for a Mere $2 12/1/2016
Top 10 Nonscientific Skills Scientists Often Lack That Can Derail Their Careers 12/1/2016
bluebird bio (BLUE), Celgene (CELG)'s Multiple Myeloma CAR-T Drug Shines in Tiny Study 12/1/2016
This One Biopharma Made the 10 Richest Companies in the U.S. List 12/1/2016
Attention, Please: Here Are 7 Career Tips From Fresh New Science Grads 12/1/2016
New Boston Biotech Axial Biotherapeutics Launches With $19.15 Million and Will be Helmed by AbbVie (ABBV)-GlaxoSmithKline (GSK) Vet 12/1/2016
10 Biotechs That Could be Bought Out Thanks to the Trump Bump 11/30/2016
CytRx (CYTR) Plans to File NDA for Once-Failed Sarcoma Drug While Columnist Raises Questions Over Efficacy and CEO Salary Amid Struggle 11/30/2016
President-Elect Trump Set to Debut Dream Team for Healthcare Reform 11/29/2016
How Rupert Murdoch and Other Big Names are Tied to the Theranos Saga 11/29/2016
Amicus (FOLD) Plummets on 3-Year Delay to U.S. Fabry Drug FDA Filing Plan 11/29/2016
Latest Deaths in Juno (JUNO) Trial Puts Unwanted Limelight on the FDA 11/29/2016
Patheon (PTHN) Takes Over Roche (RHHBY)'s North Carolina Facility, Saving 200 Jobs 11/29/2016
Novo Nordisk A/S (NVO) Yanks Ads Off of Conservative Site Founded by Trump's New Chief Strategist Stephen Bannon 11/29/2016
Pfizer (PFE) Nixes €400 Million Ireland Expansion and the Promise of 350 Jobs After Drug Setback 11/28/2016
How Donald Trump Could Disrupt the FDA 11/28/2016
Juno (JUNO) Halts CAR-T Trial for Second Time Following Additional Patient Deaths 11/28/2016
'Retired' Former Novartis AG (NVS) R&D Cancer Head Returns for a New Gig at the Dana-Farber Cancer Institute 11/28/2016
Former Allergan (AGN) Exec Who Now Helms Chase Pharma Inks $1 Billion Pact With Brent Saunders and His New Gang 11/28/2016
Famed Attorney Officially Cuts Ties With Theranos 11/28/2016
This Could be The Reason Elizabeth Holmes is Still Leading Theranos 11/23/2016
Booming Shire (SHPG) to Take Over Sanofi Genzyme (SNY)'s HQ in Kendall Square, Eyes Hiring Another 400 Employees 11/23/2016
World's Richest Doctor Patrick Soon-Shiong Meets With President-Elect Donald Trump 11/23/2016
Investors Upset as Acorda (ACOR) Abandons Development of Another Drug After Phase II Flop 11/22/2016
The 27-Year Old Who Blew Up Theranos is the Grandson of a Company Director 11/21/2016
Struggling OncoGenex (OGXI) Axes More Jobs to Conserve Cash 11/18/2016
As Eli Lilly (LLY)'s ALZ Data Looms, Here Are Some Things Investors Need to Know 11/18/2016
Famed Short-Seller Says This Drug Stock is One You Need to Drop ASAP 11/18/2016
Cambridge Upstart Magenta Therapeutics Bags $48.5 Million and Will be Helmed by Former GlaxoSmithKline (GSK) R&D Head 11/17/2016
Two Private Investigators Accuse GlaxoSmithKline (GSK) of Hiring Them Under False Pretenses 11/17/2016
The Murder of a Thermo Fisher Scientific (TMO) Employee and the Missing Thumb Drive 11/17/2016
Celgene (CELG) Exec Out as Trump Puts Vice President Elect Leader of Transition Effort 11/16/2016
Theranos Allegedly Voided 31,000 Test Reports Provided to Walgreens Customers 11/16/2016
China Takes Lead in CRISPR Race, Will Test on a Human for the First Time 11/16/2016
GlaxoSmithKline (GSK) Dumps $250 Million Into 'Smart Labs' That Will House 3,200 R&D Staffers 11/16/2016
Puma Biotech (PBYI) Crashes After Diarrhea Risk is Linked to Breast Cancer Drug in Abstract 11/16/2016
Top 10 Amgen (AMGN) Scholars to Watch Set to Impact the Future of Science and Medicine 11/16/2016
Biogen (BIIB) Taps Former Spark Therapeutics (ONCE) Exec and a Finance Vet for Hemophilia Spin-off Company Bioverativ 11/15/2016
Bay Area's Dynavax (DVAX) Plunges After the FDA Spurns HEPLISAV-B Again 11/14/2016
Bristol-Myers Squibb (BMY) Slams Down $100 Million to Make a Play Into NASH 11/14/2016
Going Up Against AbbVie (ABBV)'s Humira, Johnson & Johnson (JNJ) Presents Less-Than-Stellar Phase III Data 11/14/2016
3 Reasons That Make Biogen (BIIB) the King of a Crumbling Empire 11/14/2016
Almac Group to Expand and Create 312 New Jobs at U.S. Headquarters 11/14/2016
Celgene (CELG) Exec May be a Dark Horse Candidate for Donald Trump's Secretary of Health and Human Services 11/11/2016
Why Investors Should Buy (and Avoid) Merck & Co. (MRK) 11/11/2016
AstraZeneca PLC (AZN) Faces Another R&D Setback as Plans to File for Early Approval for Cancer Med are Scrapped 11/10/2016
Biotech Stocks Jump as Donald Trump Clinches Presidency in Major Upset 11/9/2016
FDA Slaps Clinical Hold on Arrowhead Pharma (ARWR)'s Hep B Study 11/9/2016
3 Pharmas Relying on Innovation, Not Drug Price Increases for Growth 11/9/2016
Q3 Report Reveals Kadmon Has Quietly Reduced 15% of Workforce Since July 11/9/2016
CEO Christopher Weber Trims Takeda (TKPYY)'s Fat and Builds Muscle in Much-Needed Areas 11/8/2016
2 Biotech Stocks to Have in Your Portfolio if Donald Trump Wins the Election 11/8/2016
With No Products and a Very Weak Revenue, Here's What Makes Kite Pharma (KITE) So Mighty 11/8/2016
Bone Therapeutics Taps a New CEO, Drops Plan to Initiate Cell Therapy Trial in the U.S. 11/8/2016
Merck KGaA (MKGAF.PK) Staffers Demand Severance Payments 11/7/2016
Bernie Sanders Asks the DOJ to Investigate Eli Lilly (LLY), Novo Nordisk A/S (NVO) and Sanofi (SNY) 11/7/2016
Fortress Biotech (CNDO) Forms Cellvation, Taps Forest (FRX), Life Technologies (LIFE) Alum as Interim CEO 11/7/2016
Celyad CEO Accuses Cellectis (ALCLS)' Leader of Lying About CAR-T Patent 11/4/2016
Alere (ALR) Plunges After Its Diabetes Unit Was Removed From Medicare for Allegedly Billing 211 Dead People 11/4/2016
Bay Area's Aimmune (AIMT) Gets $145 Million Infusion From Nestlé Health Science 11/4/2016
Endo International (ENDP)'s Qualitest to Lay Off 300 in Shuttering of Its North Carolina Facility 11/4/2016
Sanofi (SNY) and Novartis AG (NVS) are the Worst Culprits in Reporting Clinical Trial Data, Shire (SHPG) the Best 11/4/2016
Gearing Up for a Moonshot: FDA Desperately Seeks 400 or More Scientists 11/3/2016
Two Deaths Linked to Bristol-Myers Squibb (BMY)'s Yervoy-Opdivo Combo 11/3/2016
A Look at Amgen (AMGN) and Its $10 Billion Flop Onyx (AMGN) 11/3/2016
Four Patients Suffered Serious Adverse Events While on Roche (RHHBY)'s Breakthrough Hemophilia Drug 11/3/2016
Laid Off GlaxoSmithKline (GSK) Employees Land Gigs at Newly Formed Biotech Inimmune 11/3/2016
Tiny Novitium Pharma Relocates and Hopes to Hire 150+ New Staffers in the Next Two Years 11/3/2016
New Target: Eli Lilly (LLY) Feels the Burn of Bernie Sanders After Tweet 11/3/2016
Celldex (CLDX) Takes Out Kolltan Pharma in $235 Million Deal 11/2/2016
Former Valeant (VRX) CEO and CFO May Face Criminal Charges 11/2/2016
The $40 Billion NASH Market and the 3 Biotechs That Stand to Profit From it 11/2/2016
Facebook Ready to Take a Bite Out of Pharma and Its Cash 11/2/2016
Serial Biotech Startup Creator Third Rock Ventures Nabs a Record $616 Million 11/1/2016
Booming Cincinnati CRO Medpace Plans to Hire 650 New Employees 11/1/2016
OUCH! FDA Spurns Regeneron (REGN), Sanofi (SNY)'s RA Drug Over Plant Deficiencies 11/1/2016
Mylan (MYL)'s Meda Pharma to Shutter U.S. HQ, 94 Jobs Gone 11/1/2016
Little-Known Ganymed Grabs a $1.4 Billion Buyout Deal From Astellas (ALPMY) 10/31/2016
3 Risky Biotech Stocks to Avoid Like the Plague 10/31/2016
Merck KGaA (MKGAF.PK) Exploring Sale of Its Biosimilar Biz, Deal Could Fetch $1 Billion 10/31/2016
Amazon (AMZN) CEO, Mayo Clinic Back Bay Area Anti-Aging Firm Unity Biotech's $116 Million Funding Round 10/28/2016
Bristol-Myers Squibb (BMY) to Revamp R&D and Streamline Operations After Opdivo Failure 10/28/2016
Allergan (AGN) Takes Out GI Firm Motus in $200 Million Deal 10/28/2016
MIT Launches Ambitious Accelerator to Help Fund and Guide 'Tough' Startups 10/28/2016
23andMe Kills Its Next Generation Gene Sequencing Project, Cuts Jobs 10/27/2016
This is Why Novartis AG (NVS) Folded Its CAR-T Unit 10/27/2016
FDA Slaps Clinical Hold on AstraZeneca PLC (AZN)'s Phase III Head and Neck Cancer Program 10/27/2016
This Little Biotech in North Carolina Could be the Next Antibiotic Buyout 10/27/2016
The Only Way Troubled MannKind (MNKD) Might be Able to Avoid Bankruptcy 10/26/2016
Watch Out Juno (JUNO) and Kite Pharma (KITE): Novartis AG (NVS) Clearly Not Done With CAR-T 10/26/2016
GlaxoSmithKline (GSK) Terminates Development of Losmapimod for COPD 10/26/2016
Tiny Dipexium (DPRX) Craters After Lead Drug Locilex Flunks Phase III Trials 10/25/2016
How Florida Landed Johnson & Johnson (JNJ) and the Promise of 500 New Jobs 10/25/2016
Unnamed Fund Manager With Reliable Track Record Says High-Flying Corbus (CRBP) is About to Crash 10/25/2016
Catalent (CTLT)'s $34 Million Expansion to Create 100 New Jobs in Wisconsin 10/25/2016
Alkermes (ALKS) Rockets as Depression Drug Aces Key Late-Stage Trial 10/24/2016
Amgen (AMGN)'s Partner Unilife  (UNIS) Slashes 140 Jobs and Will Sublet Portion of Pennsylvania Office Space 10/24/2016
Why This 27-Employee Biotech is Outperforming Every Public Massachusetts Company This Year 10/24/2016
Bernie Sanders Demands Info on Ariad (ARIA)'s Leukemia Drug 10/24/2016
Alkermes (ALKS)' Success Puts the Spotlight on Cerecor, Eli Lilly (LLY)'s 2015 Deal 10/21/2016
Roche (RHHBY)'s Avastin Successor Flunks Key Study, Turns Hope to Tecentriq Instead 10/21/2016
Top 5 Best U.S. Cities for Pharma and Biotech Scientist Jobs 10/20/2016
Rigel (RIGL)'s Bleeding Disorder Drug Flunks Phase III Test, Stock Tanks 10/20/2016
Health Care Giant AmerisourceBergen (ABC) Moving Thousands Of Employees to New Carrollton Campus 10/20/2016
Biotech Goes Hollywood Again as Jennifer Lopez Set to Produce New Show About CRISPR Gene-Editing 10/20/2016
CRISPR (CRSP) IPO Brings Home $56 Million, Half of What Its Rival Took in Earlier This Year 10/20/2016
How Fast Can Kite Pharma (KITE) File for an Approval of its Lead CAR-T? 10/20/2016
Pharmascience Cuts Approximately 90 Jobs at Head Office 10/19/2016
19 Bay Area Biotechs to Watch at BIO's Investor Forum This Week 10/19/2016
Despite Bashing the Pharma Industry, More Than Half of Biotech Execs Surveyed Still Support Hillary Clinton 10/19/2016
With Ties to the Bay Area, ADC Therapeutics Pulls in $105 Million 10/19/2016
How One Tweet From Bernie Sanders Sent Ariad (ARIA)'s Stock Plunging 10/19/2016
After Hep C Flop, Has Vertex (VRTX) Learned From Its Past Mistakes? 10/18/2016
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab 10/18/2016
A Look at CRISPR, 'Biotech's Biggest Discovery of the Century,' and the 3 Companies Knee Deep in It 10/17/2016
All Eyes on Eli Lilly (LLY)'s Large-Scale Alzheimer's Trial 10/17/2016
PTC Therapeutics (PTCT) Tanks After the FDA Denies DMD Drug Translarna Again 10/17/2016
Former Novartis AG (NVS) CAR-T Scientist Jumps to TxCell to Lead CAR-Treg Research Programs 10/17/2016
The History Between a Biogen (BIIB) Drug and a High-Profile Democratic Party Fundraiser 10/17/2016
Meet Amber Salzman, the Female CEO to Helm Bay Area's Adverum Biotechnologies 10/17/2016
Watch Out, Ionis Pharma (IONS): Could This Little Biotech’s Experimental SMA Treatment Be a Threat? 10/17/2016
3 Biotechs With Cancer Drugs That Could Win Approval in 2017 10/14/2016
Tesaro (TSRO) Attempts to Squash Partner Myriad Genetics (MYGN)’ Contrary Press Release Over Niraparib 10/14/2016
Pfizer (PFE) Retracts 5 Articles Authored by Top Cancer Researcher Who Has Since Left the Company 10/14/2016
Regeneron (REGN) Bets $315 Million on Ocular Therapeutix (OCUL) for an Upgraded Form of Eylea 10/14/2016
Drug Pricing Woes Hit Vertex (VRTX) as One Mom Travels to Boston to Take on CEO 10/14/2016
Check Out These 20 Boston Area Biotechs That Spent Less on R&D This Year 10/14/2016
Google (GOOG)'s Verily to Not Only Tackle Diabetes, But Zika as Well 10/14/2016
Synairgen (SNG.L) Stock Tanks After Partner AstraZeneca PLC (AZN) Halts Asthma Drug Trial 10/12/2016
Anger Behind the Scenes When Valeant (VRX) Jacked Up Price by 2,700% for Lead Poisoning Drug 10/12/2016
Major Investor Sues Theranos Over 'Series of Lies' in $100 Million Suit 10/12/2016
Allergan (AGN) Looks to Expand Beyond Botox with Oral Migraine Treatments 10/12/2016
Why Amgen (AMGN), Biogen (BIIB) and Celgene (CELG) are the Best Biotech Stocks Now 10/11/2016
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee 10/11/2016
Tesaro (TSRO) Jumped on PARP Ovarian Cancer Win Vs. AstraZeneca PLC (AZN), AbbVie (ABBV) 10/11/2016
A Look at This Tiny Massachusetts Biotech That Could Take Down Alzheimer's 10/11/2016
Cell Phones and Documents are Seized From Some Hanmi Pharma (128940.KS) Employees on Suspicion of Insider Information Leak 10/11/2016
Embattled Theranos to Shut Down All Labs and Testing Centers, Cuts About 40% of Workforce 10/10/2016
Bristol-Myers Squibb (BMY) Looks Over Its Shoulder as Opdivo Disappoints While Merck & Co. (MRK)'s Keytruda Shines in Lung Cancer Study 10/10/2016
Retrophin (RTRX)'s R&D Head Resigns to Helm Unnamed Biotech Startup 10/7/2016
Deal Spree Continues as AstraZeneca PLC (AZN) Inks $330 Million Pact With Johnson & Johnson (JNJ) 10/7/2016
How Struggling Ariad (ARIA) Used a Safety Problem to Quietly Raise Cancer Drug Price 10/7/2016
UK's NuPharm Laboratories to Close With Loss of 66 Jobs 10/7/2016
Merck & Co. (MRK) to Slash Another 112 Jobs in Florida 10/6/2016
Novartis AG (NVS) Shakes it Up Again, Moving Singapore Facility to the Bay Area and Will Create New R&D Ops in Massachusetts and Basel 10/6/2016
CRO Biotrial, The Company That Ran Fateful Drug Trial in France, Opens Test Facility in New Jersey 10/6/2016
Metabrain Research, Medicxi Launch UK Firm Kymo Therapeutics 10/6/2016
UK's Orchard Therapeutics to Open Up Shop in the Bay Area 10/6/2016
Syncona, Cancer Research Technology Launch Achilles With $17.5 Million 10/6/2016
Pfizer (PFE) Rumored to Begin Slashing Hundreds of Employees at North Carolina Facility 10/5/2016
On a Roll, AstraZeneca PLC (AZN) Licenses Respiratory Drug to Insmed (INSM) in $150 Million Deal 10/5/2016
AstraZeneca PLC (AZN) Suffers Another Blow After Blood-Thinning Drug Flunks Trial 10/4/2016
AstraZeneca PLC (AZN) Furthers Sell-Off Strategy With New $175 Million Deal 10/4/2016
Celldex (CLDX) Who? 2 Not-as-Risky Stocks That Shot Up in the Past Year 10/4/2016
Merrimack (MACK) CEO Steps Down as Company Slashes 22% of Jobs 10/4/2016
Massachusetts VC-Backed Biotech Ra Pharma Files for $86 Million IPO 10/3/2016
Former Inyx CEO Charged in $100 Million Fraud Scheme 10/3/2016
Regeneron (REGN), Sanofi (SNY) Tout Phase III Dupixent Data 10/3/2016
Trial Failure Forces Bay Area's Threshold Pharma (THLD) to Cut Almost a Quarter of Workforce 10/3/2016
Swiss Biotech Giant Lonza Inc. to Open New Facility in Houston Suburb, Will Hire 100 Initially But Hundreds of Jobs to Come 9/30/2016
SoCal's Arrow Pharm Just Snagged a $673.5 Million Heart Deal With Amgen (AMGN) 9/30/2016
Former INSYS Sales Manager is Arrested in Opioid Kickback Scheme 9/30/2016
Denmark's LEO Pharma Opens Up Shop in Cambridge 9/30/2016
MediGene AG (MDGEF.PK), bluebird bio (BLUE) Partner Up in $1 Billion+ Cancer Immunotherapy Deal 9/29/2016
4 Biotech Stars That Will Beat the Stock Slump 9/29/2016
Boston-based Ginkgo BioWorks Opens World’s Largest Biotech Foundry to Increase Production Capacity 9/29/2016
After Emma Walmsley's Promotion, GlaxoSmithKline (GSK) Taps Former Novartis AG (NVS) Exec to Head Consumer Unit 9/29/2016
It's a Beautiful Day as U2's Bono, Others Back Bay Area Color Genomics's $45 Million Funding Round 9/29/2016
Galectin (GALT) Stock Craters After Phase IIa NASH Failure 9/28/2016
Kite Pharma (KITE) Claims Success for Phase II CAR-T Study, Stock Soars 9/28/2016
How Alkermes (ALKS) Transformed an Anti-Addiction Drug From a Bust to a Hit 9/28/2016
Drug Giant Bristol-Myers Squibb (BMY) Ties it Up With Another Bay Area Firm in Cancer Immunotherapy Quest 9/28/2016
GlaxoSmithKline (GSK) Finally Finds a Buyer for Its Paris R&D Site, 57 Staffers Affected 9/28/2016
6 Biotechs Revving Up for a Massive 50% to 150% Upside 9/28/2016
The Scientific Advisors at Theranos Won't (or Can't) Talk 9/27/2016
Neon Therapeutics Taps Former Novartis AG (NVS) Cancer Vet as New CEO 9/27/2016
Imprimis (immy) Axes 8% of Staff, Shuts Down Texas Facility 9/27/2016
North Carolina's Biologics to Pink Slip Another 132 Workers 9/26/2016
FDA Clears Amgen (AMGN) Copy of AbbVie (ABBV)'s Blockbuster Humira 9/26/2016
Shkreli Called it: Mast Therapeutics (MSTX) Begins Winding Down Vepoloxamer Programs 9/26/2016
Drumroll, Please...GlaxoSmithKline (GSK) Just Named This Woman Its New CEO 9/23/2016
H. Lundbeck A/S (LUN.CO)'s Phase III Data Crushes Hope for Alzheimer’s Once Again 9/23/2016
What's Going On With The Biotech Job Market? 9/23/2016
Valeant (VRX) Slaps 'For Sale' Sign on iNova Pharma, Deal Could Bring in $1 Billion+ 9/23/2016
35 U.S. States Sue British Drugmaker Indivior Over Marketing of Opioid 9/23/2016
Clovis Oncology (CLVS) (Once Again) Becomes a Takeover Topic, But Some Wonder Whether It's All Hype 9/23/2016
Gilead (GILD) Terminates Phase II/III Study of Ulcerative Colitis Drug 9/23/2016
Ireland Makes Its Case to Be New Home for the EMA Following Brexit 9/23/2016
Avadim Tech to Create 551 Jobs at New N.C. HQ 9/22/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic 9/22/2016
Pharma Bro Warned You: Mast Therapeutics (MSTX) Craters After Drug Flunks Phase III Test, Job Cuts Expected 9/22/2016
Calico Responds to Job Cut Rumors 9/22/2016
Allergan (AGN)'s NASH Spree Continues With $50 Million+ Buyout of San Diego's Akarna Therapeutics 9/21/2016
Struggling Eleven Bio (EBIO) Scoops Up Canadian Biotech, CEO Steps Down 9/21/2016
Vertex (VRTX) TV Show Seeks Help From Boston Heavyweights Like Matt Damon or Mark Wahlberg 9/21/2016



//-->